About CREDO

CREDO is a clinical trials unit at Austin Health. We focus on improving treatment for diabetes, metabolic conditions and cardiovascular risk through clinical research.

We conduct clinical trials to evaluate new medications, therapies and treatment approaches. Our work aims to improve patient care and long‑term health outcomes for people living with chronic metabolic conditions.

CREDO is affiliated with Australian Centre for Accelerating Diabetes Innovations (ACADI) and the Department of Medicine at the  University of Melbourne.

Patient care

Services we provide

We provide clinical research opportunities through a range of clinical trials, including:

• Clinical trials for type 1 and type 2 diabetes
• Studies in obesity, weight management and metabolic disorders
• Research into lipid disorders and cardiovascular risk
• Access to investigational treatments and new therapies
• Ongoing monitoring and support from specialist research

Accessing our care

You may be able to take part in one of our clinical trials if you are living with: 

• Type 1 diabetes
• Type 2 diabetes
• Obesity or weight management concerns
• High cholesterol or lipid disorders
• Increased cardiovascular risk

 Each study has specific eligibility criteria, and our research team will guide you through the process.

What happens after referral

After we receive your referral or expression of interest, our research team will review your details to see if you may be suitable for a current study.

If you are eligible, we will contact you to:

• Explain the study in detail
• Discuss potential risks and benefits
• Arrange screening or appointment steps

Participation in clinical trials is always voluntary. Before joining a study, our research team will explain the study in detail, including the potential risks and benefits, so you can make an informed decision.

Referral information for health professionals

We welcome referrals from general practitioners and specialists who have patients that may benefit from participation in clinical trials.

Our studies provide:

• Access to emerging therapies under specialist supervision
• Close clinical monitoring during the study period
• Communication with referring clinicians about patient participation and progress.

ITo refer a patient or learn more about current studies, please contact our research team.

Research

CREDO conducts clinical trials investigating new medications, therapies, and treatment for people with metabolic and cardiovascular conditions.

Our research areas include:

• Type 1 diabetes
• Type 2 diabetes
• Metabolic disorders
• Weight management and obesity
• Lipid disorders
• Cardiovascular risk

Our experienced clinical and research staff are committed to delivering innovative research that translates into meaningful improvements in patient care and long-term health outcomes.

Our team

Our multidisciplinary team includes endocrinologists, research nurses, clinical trial coordinators, diabetes educators and dietitians working together to deliver high‑quality clinical research.

Head of unit

Professor Elif Ekinci

Contact CREDO

Phone: 03 9496 2160 (Research Manager, Monday to Friday afternoons)

Fax: 03 9496 2672

Email: CREDO@austin.org.au

Level 1, Centaur Building
Heidelberg Repatriation Hospital
300 Waterdale Road
Heidelberg Heights Victoria